Humulin® M3

Human insulin (prb) 30% soluble insulin 70% isophane insulin

Indication

Humulin® is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Product Images

Humulin M3 Banner

Lilly committed to the supply of Humulin M3

"Lilly has no plans to withdraw Humulin M3 from the UK market and will continue to supply Humulin M3 in the UK for at least the next 5 years" (Ian Dane, Senior Director, Lilly Diabetes, 28th July 2010)

Pharmaceutical Form

Humulin® M3 is a sterile suspension of human insulin in the proportion of 30% soluble insulin to 70% isophane insulin.

Presentation

  • Humulin® M3 (Mixture 3) 100lU/ml suspension for injection in vial
  • Humulin® M3 (Mixture 3) 100lU/ml suspension for injection in cartridge
  • Humulin® M3 (Mixture 3) 100lU/ml suspension for injection in KwikPen

Downloads

Product navigation


Page tools


Welcome to Lilly Diabetes, a service provided by Eli Lilly

So that we can provide you with the most appropriate information, please choose one of the following options:

I am a healthcare PROFESSIONAL in the UK

The healthcare professional section of this website contains comprehensive information on our diabetes products and devices. Find out more about our diabetes programmes developed to support your patient care. Interactive and downloadable resources within the portal include:

  • Diabetes medical slide kits
  • Diabetes patient information leaflets
  • Interactive device tutorials

I am a member of the PUBLIC in the UK

Within this website you will find information and resources about diabetes and diabetes treatments, including leaflets for you to download, interactive tutorials and materials that you can order to your home.

 

 

 

 

 

 

 

 

UKDBT01261 August 2012

Go to TOP